Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duxil for vascular cognitive impairment without dementia
ChiCTR-TRC-08000290Phase 4Completed
- Sponsor
- Xuanwu Hospital
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of almitrine in vascular cognitive disorder (VCD) (2 arms), sponsored by Xuanwu Hospital. Primary endpoint: ADAS-cog. Started Apr 2008; status: completed.
02
Drugs
almitrine
03
Conditions
vascular cognitive disorder (VCD)
Beyond the preview
Go deeper on ChiCTR-TRC-08000290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000290.